Comments on: Physicians Expect to Decrease First- and Second- Line Use of Vytorin in Wake of ENHANCE Trial Results, According to Study by GfK Market Measures

Comments on: Physicians Expect to Decrease First- and Second- Line Use of Vytorin in Wake of ENHANCE Trial Results, According to Study by GfK Market Measures http://medicalnewsweek.com/2008/02/17/physicians-expect-to-decrease-first-and-second-line-use-of-vytorin-in-wake-of-enhance-trial-results-according-to-study-by-gfk-market-measures/ Just another Medical weblog Tue, 06 Jan 2009 07:09:53 +0000 http://wordpress.org/?v=2.2.2